IMVT
Immunovant·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IMVT Filings
Filing Date
Form Description
Form Type
2025-12-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-01
Form 144 - Report of proposed sale of securities
Ownership
2025-12-01 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-01
Form 144 - Report of proposed sale of securities
Ownership
2025-12-01 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-26
Form 144 - Report of proposed sale of securities
Ownership
2025-11-26 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-25
Form 144 - Report of proposed sale of securities
Ownership
2025-11-25 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-21
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-21 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-21
Form 8-K - Current report
Key Events
2025-11-21 · Key Events
Form 8-K - Current report
2025-11-10
Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript
Earnings Call
2025-11-10 · Earnings Call
Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript
2025-11-10
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-10 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
